mRNA Platform Market – Vaccines, Therapeutics, and Precision Medicine Drive Biotech Growth
The mRNA platform market is expanding rapidly as pharmaceutical companies, biotechnology firms, research laboratories, and governments invest in vaccines, targeted therapeutics, and next-generation genetic medicines. The market was valued at USD 6.9 billion in 2025 and is projected to reach USD 55 billion by 2035, growing at a CAGR of 23.0%. 1136
Messenger RNA, or mRNA, is a biological molecule that carries instructions for cells to produce specific proteins. mRNA platforms use these instructions to support the development of vaccines, therapies, diagnostic tools, and potential gene-editing applications. Unlike some traditional approaches, mRNA technology can be designed and adapted relatively quickly once a relevant target sequence is identified.
Read more: mRNA Platform Market